Skyrizi and Rinvoq have already replaced Humira. The $10.9B Apogee deal adds the next chapter.
Category: Top News
Manhattan Associates Just Jumped 22%. The Question Comes Next.
Three straight quarters of record bookings, a $2.47B RPO, and AI agents in production. The premium is no longer free.
KLA Is Up in 2026. July 28 Was the Real Test.
The chip world's invisible quality cop is set to report fiscal Q4 earnings.
WBD Is Trading ~20% Below the Offer Price. The Deal Just Got Delayed to 2027.
A ~$110 billion merger hit a wall this week. The arbitrage math is complicated.
Adobe Is Down 37% This Year. September 10 Is the Reset.
Record revenue, AI-first ARR tripling, and a stock at multi-year lows converge on one date.
Vistra Is Near a 52-Week Low. August 7 Could Change That.
A Meta nuclear PPA and record EBITDA are not yet in the price.
Richemont Just Shocked Luxury. LVMH Reports July 27.
Cartier's owner posted a 20% sales surge. The question is whether the sector is actually back.
Nvidia Is Down 10% From Its High. August 26 Is the Date.
Record revenue. Record profit. And the stock is still off its peak.